OSM and infarction: MINOCA patients showed a greater increase in pro-inflammatory cytokines PlGF, oncostatin M, IL-20, and CCL-15 sVCAM-1 during the early post-infarction period and in CCL-21, sVCAM-1, oncostatin M, and PlGF after one year [81].